Template:Angioimmunoblastic T-cell lymphoma: Difference between revisions

Jump to navigation Jump to search
Raviteja Reddy Guddeti (talk | contribs)
No edit summary
Sabawoon Mirwais (talk | contribs)
No edit summary
 
(9 intermediate revisions by 3 users not shown)
Line 29: Line 29:
!
!
[[Angioimmunoblastic T-cell lymphoma historical perspective|Historical Perspective]]
[[Angioimmunoblastic T-cell lymphoma historical perspective|Historical Perspective]]
|-
!
|- bgcolor="Pink"
!
[[Angioimmunoblastic T-cell lymphoma classification|Classification]]
|-  
|-  
!
!
Line 77: Line 83:
!
!
Diagnosis
Diagnosis
|-
!
|- bgcolor="LightSkyBlue"
!
[[Angioimmunoblastic T-cell lymphoma diagnostic study of choice|Diagnostic Study of Choice]]
|-  
|-  
!
!
Line 94: Line 106:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Angioimmunoblastic T-cell lymphoma laboratory findings|Laboratory Findings]]
[[Angioimmunoblastic T-cell lymphoma laboratory tests|Laboratory Findings]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Angioimmunoblastic T-cell lymphoma electrocardiogram|Electrocardiogram]]
|-  
|-  
!
!
Line 100: Line 118:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Angioimmunoblastic T-cell lymphoma chest x ray|Chest X Ray]]
[[Angioimmunoblastic T-cell lymphoma x ray|X-ray]]
|-  
|-  
!
!
Line 113: Line 131:
!
!
[[Angioimmunoblastic T-cell lymphoma MRI|MRI]]
[[Angioimmunoblastic T-cell lymphoma MRI|MRI]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Angioimmunoblastic T-cell lymphoma biopsy|Biopsy]]
|-  
|-  
!
!
Line 156: Line 180:
[[Angioimmunoblastic T-cell lymphoma primary prevention|Primary Prevention]]
[[Angioimmunoblastic T-cell lymphoma primary prevention|Primary Prevention]]
|-  
|-  
!  
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
Line 162: Line 186:
[[Angioimmunoblastic T-cell lymphoma secondary prevention|Secondary Prevention]]
[[Angioimmunoblastic T-cell lymphoma secondary prevention|Secondary Prevention]]
|-  
|-  
!  
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
Line 174: Line 198:
[[Angioimmunoblastic T-cell lymphoma future or investigational therapies|Future or Investigational Therapies]]
[[Angioimmunoblastic T-cell lymphoma future or investigational therapies|Future or Investigational Therapies]]
|-  
|-  
!  
!


|- bgcolor="CadetBlue"
|- bgcolor="CadetBlue"
Line 293: Line 317:
[http://www.google.com/search?hl=en&client=firefox-a&rls=org.mozilla%3Aen-US%3Aofficial&hs=QWo&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+AND+risk+score+OR+risk+calculator&btnG=Search Risk calculators and risk factors for {{PAGENAME}}]
[http://www.google.com/search?hl=en&client=firefox-a&rls=org.mozilla%3Aen-US%3Aofficial&hs=QWo&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+AND+risk+score+OR+risk+calculator&btnG=Search Risk calculators and risk factors for {{PAGENAME}}]
|-  
|-  
!  
!


|}
|}

Latest revision as of 21:47, 15 April 2019